Beyond public health program procurement, the Dengue Vaccine Market encompasses travel medicine and private market segments that serve distinct customer populations with different purchasing dynamics, risk profiles, and product requirements. Travelers from non-endemic to endemic regions represent a commercially attractive segment with demonstrated willingness to pay for preventive health...

"According to the latest report published by Data Bridge Market Research, the Travel Vaccine Market Data Bridge Market Research analyzes that the global travel vaccine market is expected to reach USD 13.09 billion by 2032 from USD 6.14 billion in 2023, growing at a substantial CAGR of 8.9% in the forecast period of 2024 to 2032. An all inclusive Travel Vaccine Market document...